NorthWest Biotherapeutics Inc (NWBO)

[Umibe5690]

I would definitely agree with this. Unique and well thought out technology, sterling SAB, 69 authors on the JTM supporting impressive blinded data, undoubted recognition by at least some of big P as evidenced by Dr. Duffy formerly of Merck and approaching/then joining NWBO for employment, no physician that I know of offering a well-thought out rebuttal on the science other than grapefruit juice and too early to conclude anything--it is all very compelling. There have been buyouts on significantly less positives.

If so, there has to be interest by at least some of BP, even though perhaps a majority is short sighted and arrogant. Hence, I think it reasonable to conclude that it is mainly an issue of valuation and that LP, et al know with a good deal of conviction that they have a huge new paradigm in medicine not limited to just solid tumour cancers but to many diseases by "training"/strengthening the immune system in overcoming disease. Hard to place a finite value on such an outcome.

Hopefully TLD will be announced relatively soon for patients. That is a priority. Selfishly, I hope revelation is before expiry of the warrants in April, 2020. GLTU.

Umibe